Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinson’s Disease
November 07, 2018 16:10 ET
|
Voyager Therapeutics, Inc.
CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe...